CG Labz Tirzepatide

First-in-class dual GIP and GLP-1 receptor agonist; produced the largest weight reductions of any approved peptide (SURMOUNT).

Select Strength

$80.00

$100.00

$4/mg

100 in stock

Volume Pricing

Standard1–4 units0% off

Tier A5–9 units10% off

Tier B10–24 units15% off

Tier C25–49 units22% off

Tier D50–∞ units30% off

Every batch verified. COA available.

First-in-class dual GIP and GLP-1 receptor agonist; produced the largest weight reductions of any approved peptide (SURMOUNT).